Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
OncoSec Medical Incorporated ONCS
$0.80
-$0 (-0.60%)
На 18:00, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
3598258.00000000
-
week52high
20.68
-
week52low
0.69
-
Revenue
0
-
P/E TTM
0
-
Beta
2.01072600
-
EPS
-13.43000000
-
Last Dividend
0.00000000
-
Next Earnings Date
11 дек 2020 г. в 10:59
Описание компании
OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company's lead product candidate is ImmunoPulse IL-12 that uses electroporation device to deliver a DNA-encoded interleukin-12 for reversing the immunosuppressive microenvironment in the treated tumor. It is also developing ImmunoPulse IL-12 with KEYTRUDA in patients with advanced melanoma that is in clinical trials collaboration and supply agreement (KEYNOTE-695) and metastatic triple negative breast cancer, which is in Phase II clinical trials (KEYNOTE-890); ImmunoPulse IL-12 and KEYTRUDA in patients with advanced or metastatic melanoma that has completed Phase II clinical trials; and ImmunoPulse IL-12 monotherapy in patients with metastatic melanoma, which has completed the Phase II clinical trials. In addition, the company is developing monotherapy biomarker study in patients with advanced or metastatic TNBC that has completed the Phase II clinical trials; and technology to treat liver, lung, bladder, pancreatic, and other visceral lesions. OncoSec Medical Incorporated has clinical trial collaborations with Merck & Co., Inc. and its subsidiary in connection with the KEYNOTE-695 and KEYNOTE-890 studies; a research collaboration with Duke University's Center for Applied Therapeutics to evaluate TAVO in combination or sequenced with a HER2-plasmid vaccine; a research collaboration with Roswell Park Comprehensive Cancer Center to evaluate the use of Roswell Park's intravital microscopy and enhanced IL-12 DNA-plasmid; and collaboration with Providence Cancer Institute. The company was formerly known as NetVentory Solutions Inc. and changed its name to OncoSec Medical Incorporated in March 2011. The company was incorporated in 2008 and is headquartered in Pennington, New Jersey.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| BTIG | Buy | Buy | 16 мар 2022 г. |
| BTIG | Buy | 08 мар 2021 г. | |
| H.C. Wainwright | Neutral | Buy | 25 ноя 2020 г. |
| Dawson James | Buy | 25 ноя 2020 г. | |
| Dawson James | Buy | 27 июл 2020 г. | |
| BTIG | Neutral | Buy | 14 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| DelAversano Robert J | D | 22975 | 283 | 04 ноя 2022 г. |
| Foster Spahr Stephany | A | 50000 | 50000 | 07 окт 2022 г. |
| DelAversano Robert J | D | 23258 | 284 | 05 авг 2022 г. |
| DelAversano Robert J | D | 23542 | 274 | 06 мая 2022 г. |
| Arch Robert H. | A | 700000 | 700000 | 02 мая 2022 г. |
| DelAversano Robert J | D | 23816 | 409 | 09 февр 2022 г. |
| DelAversano Robert J | D | 24225 | 343 | 01 ноя 2021 г. |
| Zhao Yuhang | A | 12000 | 4000 | 23 авг 2021 г. |
| DALESANDRO MARGARET | A | 20000 | 20000 | 23 авг 2021 г. |
| Zhao Yuhang | A | 8000 | 8000 | 20 авг 2021 г. |
Новостная лента
Avoid Common Penny Stocks Trading Mistakes With These Tips
PennyStocks
03 мар 2023 г. в 06:00
Use these tips for avoiding common penny stocks The post Avoid Common Penny Stocks Trading Mistakes With These Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
ONCS Stock: Over 120% Surge Explantion
Pulse2
01 мар 2023 г. в 10:00
The stock price of OncoSec Medical Inc (NASDAQ: ONCS) skyrocketed over 120% intraday today. This is why.
Why is OncoSec Medical (ONCS) Stock Up 91% Today?
InvestorPlace
01 мар 2023 г. в 08:05
OncoSec Medical (NASDAQ: ONCS ) stock is rising higher on Wednesday after the company withdrew a public stock offering. According to the company, it no longer wants to move forward with the offering.
Why Is OncoSec Medical (ONCS) Stock Down 25% Today?
InvestorPlace
02 февр 2023 г. в 08:47
OncoSec Medical (NASDAQ: ONCS ) stock is falling on Thursday after the company revealed details of a stock offering. The biggest news from the company's prospectus is warrants of its stock having an exercise price of $2.02 per share.
Top 5 most-shorted stocks as of December 2022
Finbold
12 дек 2022 г. в 06:52
More investors are interested in shorting and learning how they might benefit from a short squeeze as a result of the Reddit-fueled short squeeze on stocks like GameStop (NYSE: GME) and AMC Theaters (NYSE: AMC).